chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Paralysis, Positron emission tomogram normal, Scan with contrast abnormal
Clinical narrative: Presented first to a rural community hospital with 3 days of left greater than right lower extremity weakness and numbness that had progressed to the point of her inability to walk. At the rural hospital MRI indicated she had multiple intracranial lesions concerning as the etiology of her new paresthesias and weakness. She was transferred to  Medical Center for assistance obtaining a lumbar puncture where MRI redemonstrated the concerning findings, first thought to be CNS lymphoma. After extensive progression of the disease (profound weakness equating paralysis to the level of the neck) and extensive  work up including brain biopsy, it was determined she had Acute disseminated encephalomyelitis (ADEM).
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Decreased appetite, Erythema, Fatigue
Clinical narrative: Body aches and chills began approximately 6-7 hours after receiving the vaccine. The following morning I woke up at 6am with a fever, lower back pain, chills, injection site soreness accompanied by redness at the injection site and surrounding tissue. The fever reached 103 degree at it?s peak. I was nauseated and had half a cup of soup all day. I developed a mild headache and fatigue 3/26/22 until 3/29/22. At 4am 3/27 I woke up and threw up liquid only. I alternated acetaminophen and ibuprofen to relieve pain and fever from 6am 3/26 until 11pm 3/28. At the time is entry the injection site area is still red and tender.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site erythema, Injection site pain, Nausea, Pain
Clinical narrative: Body aches and chills began approximately 6-7 hours after receiving the vaccine. The following morning I woke up at 6am with a fever, lower back pain, chills, injection site soreness accompanied by redness at the injection site and surrounding tissue. The fever reached 103 degree at it?s peak. I was nauseated and had half a cup of soup all day. I developed a mild headache and fatigue 3/26/22 until 3/29/22. At 4am 3/27 I woke up and threw up liquid only. I alternated acetaminophen and ibuprofen to relieve pain and fever from 6am 3/26 until 11pm 3/28. At the time is entry the injection site area is still red and tender.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Body aches and chills began approximately 6-7 hours after receiving the vaccine. The following morning I woke up at 6am with a fever, lower back pain, chills, injection site soreness accompanied by redness at the injection site and surrounding tissue. The fever reached 103 degree at it?s peak. I was nauseated and had half a cup of soup all day. I developed a mild headache and fatigue 3/26/22 until 3/29/22. At 4am 3/27 I woke up and threw up liquid only. I alternated acetaminophen and ibuprofen to relieve pain and fever from 6am 3/26 until 11pm 3/28. At the time is entry the injection site area is still red and tender.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No symptoms per mom, child was  fine.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Sudden death
Clinical narrative: Patient expired Sudden Death In sleep 2/3/22 No warning signs
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cardiac arrest, Cardiac ventricular disorder, Chest X-ray, Echocardiogram
Clinical narrative: 03/24/2021 it was about 6pm to get my vaccine and about 5 mins after my body was in full hives and my airway started closing. I was rushed to the hospital. Two weeks later I fainted and was rushed back to the hospital. My heart stopped twice. I was put on the Holter monitor, my heart rate was either too low or too high. I was diagnosed with the ventricle going to heart was scarred. I was put on a blood pressure medication or heart stabilization medication. It took about 8 months to get a normal heart rate.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Electrocardiogram ambulatory, Fear, Heart rate decreased, Heart rate increased
Clinical narrative: 03/24/2021 it was about 6pm to get my vaccine and about 5 mins after my body was in full hives and my airway started closing. I was rushed to the hospital. Two weeks later I fainted and was rushed back to the hospital. My heart stopped twice. I was put on the Holter monitor, my heart rate was either too low or too high. I was diagnosed with the ventricle going to heart was scarred. I was put on a blood pressure medication or heart stabilization medication. It took about 8 months to get a normal heart rate.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Throat tightness, Urticaria
Clinical narrative: 03/24/2021 it was about 6pm to get my vaccine and about 5 mins after my body was in full hives and my airway started closing. I was rushed to the hospital. Two weeks later I fainted and was rushed back to the hospital. My heart stopped twice. I was put on the Holter monitor, my heart rate was either too low or too high. I was diagnosed with the ventricle going to heart was scarred. I was put on a blood pressure medication or heart stabilization medication. It took about 8 months to get a normal heart rate.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain
Clinical narrative: HORRIBLE ABDOMINAL PAINS; This spontaneous report received from a patient via social media through a company representative concerned a 45 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number: unknown and expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date (60 hours after vaccination), the patient woke up with horrible abdominal pain. 12 hours after waking up with horrible pain patient further had his appendix removed. As per reporter, "45 year old male here. I had the J&J vaccine. 60 hours later, I woke up with horrible abdominal pains. 12 hours after waking up with horrible abdominal pains, I was having my appendix removed". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of horrible abdominal pains was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20220350690-Covid-19 vaccine ad26.CoV-2.s- Horrible abdominal pains. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Carotid artery occlusion, Ischaemic stroke
Clinical narrative: stroke with 100% blockage in left carotid artery and 80% blockage in brain; stroke with 100% blockage in left carotid artery and 80% blockage in brain; This is a spontaneous report received from contactable reporter (consumer) for a Pfizer sponsored program. The reporter is the patient.  A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 01May2021 (Batch/Lot number: unknown) at the age of 55-years as dose 2, single for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: COVID-19 Vaccine (DOSE 1, MANUFACTURER UNKNOWN), administration date: Apr2021, for COVID-19 immunisation. The following information was reported: ISCHAEMIC STROKE (hospitalization, medically significant) and CAROTID ARTERY OCCLUSION (hospitalization, medically significant) all with onset 02May2021, outcome "unknown" and all described as "stroke with 100% blockage in left carotid artery and 80% blockage in brain." The patient was hospitalized for ischaemic stroke and carotid artery occlusion (start date: 02May2021, discharge date: May2021). The event "stroke with 100% blockage in left carotid artery and 80% blockage in brain" was evaluated at the physician office visit. Therapeutic measures were taken as a result of ischaemic stroke and carotid artery occlusion. Clinical course: The patient received the first dose of the COVID-19 vaccine in Apr2021 and then he took his second dose on 01May2021. On 02May2021, he experienced a stroke with 100% blockage in his left carotid artery and 80% blockage in his brain. He then mentioned that this was just crazy because he was now taking anti-seizure medication, anti-anxiety medication, mood medication, and he was on 3 different blood thinners to where if he was scratched, he will bleed profusely; he also mentioned that he was on a multivitamin. There was no way he could work, and he couldn't drive since his neurologist hasn't cleared him to do so. They performed a procedure through his femoral artery and took photos of the blockage in his neck and brain. He was hospitalized from that Sunday, 02May2021 until May2021 (also reported as either Thursday or Friday).   The lot number for BNT162B2 was not provided and will be requested during follow-up.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Bronchial wall thickening, C-reactive protein increased, Chest X-ray abnormal, Conjunctival hyperaemia
Clinical narrative: Patient developed symptoms of MISC on 11/7/21; fevers also began on 11/7/21.  Over the course of illness, symptoms and complications included fevers, shock, hypotension, sinus tachycardia, abdominal pain, vomiting, rash, mucocutaneous lesions/conjunctival injection, and myalgias. Abnormal labs included elevated troponin, elevated NT-ProBNP, elevated CRP, and elevated ferritin. ECHO studies showed pleural effusion, left ventricular dysfunction/decreased function, and coronary artery dilatation (first detected on 11/15/21). Patient was admitted to the hospital on 11/11/21 and treated with LFNC oxygen, epinephrine/norepinephrine, IVIG, infliximab, and aspirin. He was in the PICU from 11/11/21 to 11/12/21. He was discharged on 11/17/2021.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary artery dilatation, Echocardiogram abnormal, Hypotension, Immunoglobulin therapy, Intensive care
Clinical narrative: Patient developed symptoms of MISC on 11/7/21; fevers also began on 11/7/21.  Over the course of illness, symptoms and complications included fevers, shock, hypotension, sinus tachycardia, abdominal pain, vomiting, rash, mucocutaneous lesions/conjunctival injection, and myalgias. Abnormal labs included elevated troponin, elevated NT-ProBNP, elevated CRP, and elevated ferritin. ECHO studies showed pleural effusion, left ventricular dysfunction/decreased function, and coronary artery dilatation (first detected on 11/15/21). Patient was admitted to the hospital on 11/11/21 and treated with LFNC oxygen, epinephrine/norepinephrine, IVIG, infliximab, and aspirin. He was in the PICU from 11/11/21 to 11/12/21. He was discharged on 11/17/2021.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Left ventricular dysfunction, Mitral valve incompetence, Mucocutaneous ulceration, Multisystem inflammatory syndrome in children, Myalgia
Clinical narrative: Patient developed symptoms of MISC on 11/7/21; fevers also began on 11/7/21.  Over the course of illness, symptoms and complications included fevers, shock, hypotension, sinus tachycardia, abdominal pain, vomiting, rash, mucocutaneous lesions/conjunctival injection, and myalgias. Abnormal labs included elevated troponin, elevated NT-ProBNP, elevated CRP, and elevated ferritin. ECHO studies showed pleural effusion, left ventricular dysfunction/decreased function, and coronary artery dilatation (first detected on 11/15/21). Patient was admitted to the hospital on 11/11/21 and treated with LFNC oxygen, epinephrine/norepinephrine, IVIG, infliximab, and aspirin. He was in the PICU from 11/11/21 to 11/12/21. He was discharged on 11/17/2021.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: N-terminal prohormone brain natriuretic peptide increased, Pleural effusion, Pyrexia, Rash, SARS-CoV-2 antibody test
Clinical narrative: Patient developed symptoms of MISC on 11/7/21; fevers also began on 11/7/21.  Over the course of illness, symptoms and complications included fevers, shock, hypotension, sinus tachycardia, abdominal pain, vomiting, rash, mucocutaneous lesions/conjunctival injection, and myalgias. Abnormal labs included elevated troponin, elevated NT-ProBNP, elevated CRP, and elevated ferritin. ECHO studies showed pleural effusion, left ventricular dysfunction/decreased function, and coronary artery dilatation (first detected on 11/15/21). Patient was admitted to the hospital on 11/11/21 and treated with LFNC oxygen, epinephrine/norepinephrine, IVIG, infliximab, and aspirin. He was in the PICU from 11/11/21 to 11/12/21. He was discharged on 11/17/2021.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Serum ferritin increased, Shock, Sinus tachycardia, Troponin increased
Clinical narrative: Patient developed symptoms of MISC on 11/7/21; fevers also began on 11/7/21.  Over the course of illness, symptoms and complications included fevers, shock, hypotension, sinus tachycardia, abdominal pain, vomiting, rash, mucocutaneous lesions/conjunctival injection, and myalgias. Abnormal labs included elevated troponin, elevated NT-ProBNP, elevated CRP, and elevated ferritin. ECHO studies showed pleural effusion, left ventricular dysfunction/decreased function, and coronary artery dilatation (first detected on 11/15/21). Patient was admitted to the hospital on 11/11/21 and treated with LFNC oxygen, epinephrine/norepinephrine, IVIG, infliximab, and aspirin. He was in the PICU from 11/11/21 to 11/12/21. He was discharged on 11/17/2021.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient developed symptoms of MISC on 11/7/21; fevers also began on 11/7/21.  Over the course of illness, symptoms and complications included fevers, shock, hypotension, sinus tachycardia, abdominal pain, vomiting, rash, mucocutaneous lesions/conjunctival injection, and myalgias. Abnormal labs included elevated troponin, elevated NT-ProBNP, elevated CRP, and elevated ferritin. ECHO studies showed pleural effusion, left ventricular dysfunction/decreased function, and coronary artery dilatation (first detected on 11/15/21). Patient was admitted to the hospital on 11/11/21 and treated with LFNC oxygen, epinephrine/norepinephrine, IVIG, infliximab, and aspirin. He was in the PICU from 11/11/21 to 11/12/21. He was discharged on 11/17/2021.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Alcohol test negative, Angiogram pulmonary normal, Blood creatinine increased, Blood gases normal
Clinical narrative: Patient is completely encephalopathic when she arrives, not appropriately responding to voice or other stimuli.  Is awake with eyes open mumbling incoherently and having myoclonic twitches throughout.     Patient had been hospitalized x2 with COVID pneumonia.  Once in November of 2021 and once more recently with diagnosis 02/21/2022.  The latter she was hospitalized via tele med an outside facility.  Had been treated with clindamycin for bronchitis prior.  Was hypoxic on admission.  Was treated with dexamethasone during her stay as well as continued at discharge as well as remdesivir from the 21st through the 25th.  Discharge the 25th home.  On the 28th was seen in the emergency department locally with sciatica.  Prescribed oxycodone for 3 days for pain.  Already on baclofen at home.  Presented again today after being found down at home by family.  Obtunded on arrival.  Workup included CT C-spine which had motion artifact but no gross abnormalities other than a left upper lobe opacity.  CT head which was unremarkable.  Chest x-ray which was unremarkable.  Of note did have a CT angio for PE on the 21st which was negative.  Lab work significant for an acute kidney injury with a creatinine up to 3.94, elevated lactate at 2.1 which did come down with fluids, elevated potassium at 5.6 and leukocytosis though of note the patient was on steroids at home and had had leukocytosis prior.  Urinalysis was obtained though not convincing for infection.  LFTs normal.  Alcohol negative.  Drug screen negative other than expected opioids. VBG unremarkable.  Given 2 L of normal saline.  Discussion had with Nephrology who felt this likely represented acute kidney injury and resultant baclofen toxicity.  Transferred for likely dialysis.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood lactic acid increased, Blood potassium increased, Bronchitis, COVID-19 pneumonia, Chest X-ray normal
Clinical narrative: Patient is completely encephalopathic when she arrives, not appropriately responding to voice or other stimuli.  Is awake with eyes open mumbling incoherently and having myoclonic twitches throughout.     Patient had been hospitalized x2 with COVID pneumonia.  Once in November of 2021 and once more recently with diagnosis 02/21/2022.  The latter she was hospitalized via tele med an outside facility.  Had been treated with clindamycin for bronchitis prior.  Was hypoxic on admission.  Was treated with dexamethasone during her stay as well as continued at discharge as well as remdesivir from the 21st through the 25th.  Discharge the 25th home.  On the 28th was seen in the emergency department locally with sciatica.  Prescribed oxycodone for 3 days for pain.  Already on baclofen at home.  Presented again today after being found down at home by family.  Obtunded on arrival.  Workup included CT C-spine which had motion artifact but no gross abnormalities other than a left upper lobe opacity.  CT head which was unremarkable.  Chest x-ray which was unremarkable.  Of note did have a CT angio for PE on the 21st which was negative.  Lab work significant for an acute kidney injury with a creatinine up to 3.94, elevated lactate at 2.1 which did come down with fluids, elevated potassium at 5.6 and leukocytosis though of note the patient was on steroids at home and had had leukocytosis prior.  Urinalysis was obtained though not convincing for infection.  LFTs normal.  Alcohol negative.  Drug screen negative other than expected opioids. VBG unremarkable.  Given 2 L of normal saline.  Discussion had with Nephrology who felt this likely represented acute kidney injury and resultant baclofen toxicity.  Transferred for likely dialysis.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Computerised tomogram head normal, Computerised tomogram spine, Depressed level of consciousness, Drug screen negative
Clinical narrative: Patient is completely encephalopathic when she arrives, not appropriately responding to voice or other stimuli.  Is awake with eyes open mumbling incoherently and having myoclonic twitches throughout.     Patient had been hospitalized x2 with COVID pneumonia.  Once in November of 2021 and once more recently with diagnosis 02/21/2022.  The latter she was hospitalized via tele med an outside facility.  Had been treated with clindamycin for bronchitis prior.  Was hypoxic on admission.  Was treated with dexamethasone during her stay as well as continued at discharge as well as remdesivir from the 21st through the 25th.  Discharge the 25th home.  On the 28th was seen in the emergency department locally with sciatica.  Prescribed oxycodone for 3 days for pain.  Already on baclofen at home.  Presented again today after being found down at home by family.  Obtunded on arrival.  Workup included CT C-spine which had motion artifact but no gross abnormalities other than a left upper lobe opacity.  CT head which was unremarkable.  Chest x-ray which was unremarkable.  Of note did have a CT angio for PE on the 21st which was negative.  Lab work significant for an acute kidney injury with a creatinine up to 3.94, elevated lactate at 2.1 which did come down with fluids, elevated potassium at 5.6 and leukocytosis though of note the patient was on steroids at home and had had leukocytosis prior.  Urinalysis was obtained though not convincing for infection.  LFTs normal.  Alcohol negative.  Drug screen negative other than expected opioids. VBG unremarkable.  Given 2 L of normal saline.  Discussion had with Nephrology who felt this likely represented acute kidney injury and resultant baclofen toxicity.  Transferred for likely dialysis.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Encephalopathy, Hyporesponsive to stimuli, Hypoxia, Incoherent, Laboratory test abnormal
Clinical narrative: Patient is completely encephalopathic when she arrives, not appropriately responding to voice or other stimuli.  Is awake with eyes open mumbling incoherently and having myoclonic twitches throughout.     Patient had been hospitalized x2 with COVID pneumonia.  Once in November of 2021 and once more recently with diagnosis 02/21/2022.  The latter she was hospitalized via tele med an outside facility.  Had been treated with clindamycin for bronchitis prior.  Was hypoxic on admission.  Was treated with dexamethasone during her stay as well as continued at discharge as well as remdesivir from the 21st through the 25th.  Discharge the 25th home.  On the 28th was seen in the emergency department locally with sciatica.  Prescribed oxycodone for 3 days for pain.  Already on baclofen at home.  Presented again today after being found down at home by family.  Obtunded on arrival.  Workup included CT C-spine which had motion artifact but no gross abnormalities other than a left upper lobe opacity.  CT head which was unremarkable.  Chest x-ray which was unremarkable.  Of note did have a CT angio for PE on the 21st which was negative.  Lab work significant for an acute kidney injury with a creatinine up to 3.94, elevated lactate at 2.1 which did come down with fluids, elevated potassium at 5.6 and leukocytosis though of note the patient was on steroids at home and had had leukocytosis prior.  Urinalysis was obtained though not convincing for infection.  LFTs normal.  Alcohol negative.  Drug screen negative other than expected opioids. VBG unremarkable.  Given 2 L of normal saline.  Discussion had with Nephrology who felt this likely represented acute kidney injury and resultant baclofen toxicity.  Transferred for likely dialysis.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Leukocytosis, Liver function test normal, Lung opacity, Myoclonus, Pain
Clinical narrative: Patient is completely encephalopathic when she arrives, not appropriately responding to voice or other stimuli.  Is awake with eyes open mumbling incoherently and having myoclonic twitches throughout.     Patient had been hospitalized x2 with COVID pneumonia.  Once in November of 2021 and once more recently with diagnosis 02/21/2022.  The latter she was hospitalized via tele med an outside facility.  Had been treated with clindamycin for bronchitis prior.  Was hypoxic on admission.  Was treated with dexamethasone during her stay as well as continued at discharge as well as remdesivir from the 21st through the 25th.  Discharge the 25th home.  On the 28th was seen in the emergency department locally with sciatica.  Prescribed oxycodone for 3 days for pain.  Already on baclofen at home.  Presented again today after being found down at home by family.  Obtunded on arrival.  Workup included CT C-spine which had motion artifact but no gross abnormalities other than a left upper lobe opacity.  CT head which was unremarkable.  Chest x-ray which was unremarkable.  Of note did have a CT angio for PE on the 21st which was negative.  Lab work significant for an acute kidney injury with a creatinine up to 3.94, elevated lactate at 2.1 which did come down with fluids, elevated potassium at 5.6 and leukocytosis though of note the patient was on steroids at home and had had leukocytosis prior.  Urinalysis was obtained though not convincing for infection.  LFTs normal.  Alcohol negative.  Drug screen negative other than expected opioids. VBG unremarkable.  Given 2 L of normal saline.  Discussion had with Nephrology who felt this likely represented acute kidney injury and resultant baclofen toxicity.  Transferred for likely dialysis.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sciatica, Speech disorder, Toxicity to various agents, Urine analysis normal
Clinical narrative: Patient is completely encephalopathic when she arrives, not appropriately responding to voice or other stimuli.  Is awake with eyes open mumbling incoherently and having myoclonic twitches throughout.     Patient had been hospitalized x2 with COVID pneumonia.  Once in November of 2021 and once more recently with diagnosis 02/21/2022.  The latter she was hospitalized via tele med an outside facility.  Had been treated with clindamycin for bronchitis prior.  Was hypoxic on admission.  Was treated with dexamethasone during her stay as well as continued at discharge as well as remdesivir from the 21st through the 25th.  Discharge the 25th home.  On the 28th was seen in the emergency department locally with sciatica.  Prescribed oxycodone for 3 days for pain.  Already on baclofen at home.  Presented again today after being found down at home by family.  Obtunded on arrival.  Workup included CT C-spine which had motion artifact but no gross abnormalities other than a left upper lobe opacity.  CT head which was unremarkable.  Chest x-ray which was unremarkable.  Of note did have a CT angio for PE on the 21st which was negative.  Lab work significant for an acute kidney injury with a creatinine up to 3.94, elevated lactate at 2.1 which did come down with fluids, elevated potassium at 5.6 and leukocytosis though of note the patient was on steroids at home and had had leukocytosis prior.  Urinalysis was obtained though not convincing for infection.  LFTs normal.  Alcohol negative.  Drug screen negative other than expected opioids. VBG unremarkable.  Given 2 L of normal saline.  Discussion had with Nephrology who felt this likely represented acute kidney injury and resultant baclofen toxicity.  Transferred for likely dialysis.
Age: 70.0
Sex: F
Vaccine: COVID19, FLU4, COVID19, FLU4
Symptoms: Biopsy lung abnormal, Bronchoscopy abnormal, Computerised tomogram thorax abnormal, Cough, Culture negative
Clinical narrative: about 10 hours after shot:  Fever, chills, fatigue;   next day added headache
Age: 70.0
Sex: F
Vaccine: COVID19, FLU4, COVID19, FLU4
Symptoms: Dyspnoea, Lung infiltration, Malaise, Organising pneumonia, White blood cell count increased
Clinical narrative: about 10 hours after shot:  Fever, chills, fatigue;   next day added headache
Age: 70.0
Sex: F
Vaccine: COVID19, FLU4, COVID19, FLU4
Symptoms: Biopsy lung abnormal, Bronchoscopy abnormal, Chest X-ray abnormal, Chills, Computerised tomogram thorax abnormal
Clinical narrative: about 10 hours after shot:  Fever, chills, fatigue;   next day added headache
Age: 70.0
Sex: F
Vaccine: COVID19, FLU4, COVID19, FLU4
Symptoms: Fatigue, Headache, Magnetic resonance imaging abnormal, Pneumonia, Pyrexia
Clinical narrative: about 10 hours after shot:  Fever, chills, fatigue;   next day added headache
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiopulmonary bypass, Coronary artery bypass
Clinical narrative: Patient admitted for coronary angiogram due to abnormal stress test on 11/3/21. Patient hospitalized on 11/15/21 for CABG. These visits are within 6 weeks of receiving covid vaccination.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arteriogram coronary abnormal, Cardiac stress test abnormal, Coronary artery bypass
Clinical narrative: Patient admitted for coronary angiogram due to abnormal stress test on 11/3/21. Patient hospitalized on 11/15/21 for CABG. These visits are within 6 weeks of receiving covid vaccination.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus - both ears; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Aug2021 (Lot number: Ew0187) at the age of 51 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: TINNITUS (non-serious) with onset 29Aug2021, outcome "recovering", described as "Tinnitus - both ears". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tinnitus.  Additional Information : Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Device Date was 10Mar2022.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Tinnitus
Clinical narrative: Tinnitus - both ears; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Aug2021 (Lot number: Ew0187) at the age of 51 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: TINNITUS (non-serious) with onset 29Aug2021, outcome "recovering", described as "Tinnitus - both ears". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tinnitus.  Additional Information : Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Device Date was 10Mar2022.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Balance disorder, Heart rate increased, Myalgia, Sluggishness
Clinical narrative: Woke up feeling like concrete block/overall wonky feeling; sore back muscles and neck; imbalance; bladder incontinence; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2022 14:15 (Lot number: FK9729) as dose 4 (booster),single for covid-19 immunisation. Relevant medical history included: "CLL" (unspecified if ongoing); "MS" (unspecified if ongoing). Concomitant medication(s) included: BACLOFEN; BUPROPION; TOVIAZ; DALFAMPRIDINE; VITAMIN C [ASCORBIC ACID]; VITAMIN D [ERGOCALCIFEROL]; VITAMIN E. Past drug history included: Known allergy: oxybutinin, reaction(s): "Allergy"; Known allergy: trospium cl, reaction(s): "Allergy"; Known allergy: myrbetriq, reaction(s): "Allergy"; Known allergy: sulfonamides, reaction(s): "Allergy"; Known allergy: nickel on skin, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 Immunization; Bnt162b2 (DOSE 2), for COVID-19 Immunization; Bnt162b2 (DOSE 3), for COVID-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "Woke up feeling like concrete block/overall wonky feeling"; MYALGIA (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "sore back muscles and neck"; BALANCE DISORDER (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "imbalance"; URINARY INCONTINENCE (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "bladder incontinence". Therapeutic measures were not taken as a result of feeling abnormal, myalgia, balance disorder, urinary incontinence. Additional information; The patient did not get any treatment. The patient did not get any covid prior vaccination. The patient did not get any covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Woke up feeling like concrete block/overall wonky feeling; sore back muscles and neck; imbalance; bladder incontinence; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2022 14:15 (Lot number: FK9729) as dose 4 (booster),single for covid-19 immunisation. Relevant medical history included: "CLL" (unspecified if ongoing); "MS" (unspecified if ongoing). Concomitant medication(s) included: BACLOFEN; BUPROPION; TOVIAZ; DALFAMPRIDINE; VITAMIN C [ASCORBIC ACID]; VITAMIN D [ERGOCALCIFEROL]; VITAMIN E. Past drug history included: Known allergy: oxybutinin, reaction(s): "Allergy"; Known allergy: trospium cl, reaction(s): "Allergy"; Known allergy: myrbetriq, reaction(s): "Allergy"; Known allergy: sulfonamides, reaction(s): "Allergy"; Known allergy: nickel on skin, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 Immunization; Bnt162b2 (DOSE 2), for COVID-19 Immunization; Bnt162b2 (DOSE 3), for COVID-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "Woke up feeling like concrete block/overall wonky feeling"; MYALGIA (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "sore back muscles and neck"; BALANCE DISORDER (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "imbalance"; URINARY INCONTINENCE (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "bladder incontinence". Therapeutic measures were not taken as a result of feeling abnormal, myalgia, balance disorder, urinary incontinence. Additional information; The patient did not get any treatment. The patient did not get any covid prior vaccination. The patient did not get any covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Feeling abnormal, Myalgia, Urinary incontinence
Clinical narrative: Woke up feeling like concrete block/overall wonky feeling; sore back muscles and neck; imbalance; bladder incontinence; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2022 14:15 (Lot number: FK9729) as dose 4 (booster),single for covid-19 immunisation. Relevant medical history included: "CLL" (unspecified if ongoing); "MS" (unspecified if ongoing). Concomitant medication(s) included: BACLOFEN; BUPROPION; TOVIAZ; DALFAMPRIDINE; VITAMIN C [ASCORBIC ACID]; VITAMIN D [ERGOCALCIFEROL]; VITAMIN E. Past drug history included: Known allergy: oxybutinin, reaction(s): "Allergy"; Known allergy: trospium cl, reaction(s): "Allergy"; Known allergy: myrbetriq, reaction(s): "Allergy"; Known allergy: sulfonamides, reaction(s): "Allergy"; Known allergy: nickel on skin, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 Immunization; Bnt162b2 (DOSE 2), for COVID-19 Immunization; Bnt162b2 (DOSE 3), for COVID-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "Woke up feeling like concrete block/overall wonky feeling"; MYALGIA (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "sore back muscles and neck"; BALANCE DISORDER (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "imbalance"; URINARY INCONTINENCE (non-serious) with onset 12Mar2022 03:00, outcome "recovering", described as "bladder incontinence". Therapeutic measures were not taken as a result of feeling abnormal, myalgia, balance disorder, urinary incontinence. Additional information; The patient did not get any treatment. The patient did not get any covid prior vaccination. The patient did not get any covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alopecia areata, Blood thyroid stimulating hormone normal, Haemoglobin decreased, Laboratory test, Red blood cell count normal
Clinical narrative: turned into ABSOLUTE BALDING / vaccine has done permanent damage to the patient; thinning of eyebrows and loss of eyelashes now; permanent damage to the patient - physically and emotionally; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 6 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Dec2021 (Lot number: FK5618) at the age of 6 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergies pollen" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5127, Location of injection: Arm Right), administration date: 02Dec2021, when the patient was 6 years old, for COVID-19 immunization. There was no other vaccine in four weeks. COVID was not tested prior vaccination. It was unknown if COVID was tested post vaccination.  The following information was reported: ALOPECIA (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "turned into ABSOLUTE BALDING / vaccine has done permanent damage to the patient"; MADAROSIS (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "thinning of eyebrows and loss of eyelashes now"; EMOTIONAL DISTRESS (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "permanent damage to the patient - physically and emotionally". The events "turned into absolute balding / vaccine has done permanent damage to the patient", "thinning of eyebrows and loss of eyelashes now" and "permanent damage to the patient - physically and emotionally" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of alopecia, madarosis, emotional distress.   Clinical course: The 2nd covid shot was on 23Dec2021. About 3 weeks after that reporter started noticing hairfall on the scalp. More hair fell every day and after 6 weeks it turned into ABSOLUTE BALDING. They were also noticing thinning of eyebrows and loss of eyelashes now. This is ridiculous; the Pfizer vaccine has done permanent damage to the patient - physically and emotionally.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thyroxine free, White blood cell count normal
Clinical narrative: turned into ABSOLUTE BALDING / vaccine has done permanent damage to the patient; thinning of eyebrows and loss of eyelashes now; permanent damage to the patient - physically and emotionally; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 6 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Dec2021 (Lot number: FK5618) at the age of 6 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergies pollen" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5127, Location of injection: Arm Right), administration date: 02Dec2021, when the patient was 6 years old, for COVID-19 immunization. There was no other vaccine in four weeks. COVID was not tested prior vaccination. It was unknown if COVID was tested post vaccination.  The following information was reported: ALOPECIA (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "turned into ABSOLUTE BALDING / vaccine has done permanent damage to the patient"; MADAROSIS (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "thinning of eyebrows and loss of eyelashes now"; EMOTIONAL DISTRESS (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "permanent damage to the patient - physically and emotionally". The events "turned into absolute balding / vaccine has done permanent damage to the patient", "thinning of eyebrows and loss of eyelashes now" and "permanent damage to the patient - physically and emotionally" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of alopecia, madarosis, emotional distress.   Clinical course: The 2nd covid shot was on 23Dec2021. About 3 weeks after that reporter started noticing hairfall on the scalp. More hair fell every day and after 6 weeks it turned into ABSOLUTE BALDING. They were also noticing thinning of eyebrows and loss of eyelashes now. This is ridiculous; the Pfizer vaccine has done permanent damage to the patient - physically and emotionally.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alopecia, Emotional distress, Madarosis
Clinical narrative: turned into ABSOLUTE BALDING / vaccine has done permanent damage to the patient; thinning of eyebrows and loss of eyelashes now; permanent damage to the patient - physically and emotionally; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 6 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Dec2021 (Lot number: FK5618) at the age of 6 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergies pollen" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5127, Location of injection: Arm Right), administration date: 02Dec2021, when the patient was 6 years old, for COVID-19 immunization. There was no other vaccine in four weeks. COVID was not tested prior vaccination. It was unknown if COVID was tested post vaccination.  The following information was reported: ALOPECIA (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "turned into ABSOLUTE BALDING / vaccine has done permanent damage to the patient"; MADAROSIS (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "thinning of eyebrows and loss of eyelashes now"; EMOTIONAL DISTRESS (disability, medically significant) with onset 13Jan2022, outcome "not recovered", described as "permanent damage to the patient - physically and emotionally". The events "turned into absolute balding / vaccine has done permanent damage to the patient", "thinning of eyebrows and loss of eyelashes now" and "permanent damage to the patient - physically and emotionally" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of alopecia, madarosis, emotional distress.   Clinical course: The 2nd covid shot was on 23Dec2021. About 3 weeks after that reporter started noticing hairfall on the scalp. More hair fell every day and after 6 weeks it turned into ABSOLUTE BALDING. They were also noticing thinning of eyebrows and loss of eyelashes now. This is ridiculous; the Pfizer vaccine has done permanent damage to the patient - physically and emotionally.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Rash
Clinical narrative: rash/rash on my legs; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 11Feb2021 (Lot number: Em9810) at the age of 74 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Controlled hypertension" (unspecified if ongoing); "Triple bypass" (unspecified if ongoing), notes: pertinent details: heart surgery. The patient took concomitant medications. The following information was reported: RASH (non-serious), outcome "recovered", described as "rash/rash on my legs". The event "rash/rash on my legs" was evaluated at the physician office visit. Therapeutic measures were taken as a result of rash.  Additional information: It was reported that she had my two COVID-19 shots (Pfizer COVID-19 Vaccine), plus her booster and have had a reaction after each of them that have reported to Pfizer through the, via the internet. After the first shot, she broke out in a rash. After the second shot, she developed joint pain in knees and wrist. After the booster, which she got 26Nov. She believed, in her left arm, she have continued to have soreness in this arm. She still have soreness and now the pain and numbness is moving down her arm into her fingers to the point that it is difficult for her to move fingers. She went to primary care in Jan and she said we are going to watch it, she checked her armpits. She went back in the 01Feb, she checked for lymph node swelling, which there was none and she said all she could think of right then was to give me something for the pain.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: rash/rash on my legs; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 11Feb2021 (Lot number: Em9810) at the age of 74 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Controlled hypertension" (unspecified if ongoing); "Triple bypass" (unspecified if ongoing), notes: pertinent details: heart surgery. The patient took concomitant medications. The following information was reported: RASH (non-serious), outcome "recovered", described as "rash/rash on my legs". The event "rash/rash on my legs" was evaluated at the physician office visit. Therapeutic measures were taken as a result of rash.  Additional information: It was reported that she had my two COVID-19 shots (Pfizer COVID-19 Vaccine), plus her booster and have had a reaction after each of them that have reported to Pfizer through the, via the internet. After the first shot, she broke out in a rash. After the second shot, she developed joint pain in knees and wrist. After the booster, which she got 26Nov. She believed, in her left arm, she have continued to have soreness in this arm. She still have soreness and now the pain and numbness is moving down her arm into her fingers to the point that it is difficult for her to move fingers. She went to primary care in Jan and she said we are going to watch it, she checked her armpits. She went back in the 01Feb, she checked for lymph node swelling, which there was none and she said all she could think of right then was to give me something for the pain.
Age: 25.0
Sex: M
Vaccine: ANTH
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient was given 3rd anthrax dose 4 months too early. The second was received on August 18th, 2021. No adverse events experienced from patient.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Heart rate increased, Inflammatory marker increased
Clinical narrative: 11 hour sustained heart rate over 100 while sedentary and sleeping. Unexpected spikes to 140. Since event has had intermittent chest pain.